Eli Lilly CEO pushes back on Dario Amodei's 'ludicrous' medical AI claims
Noaidi · hn · 2026-11-13
Gary Marcus reports that Eli Lilly's CEO has become the latest executive to publicly rebut Anthropic CEO Dario Amodei's aggressive claims about AI's medical potential, calling them "ludicrous." The clash highlights a widening split between pharma leadership and AI founders over how transformative AI will actually be in medicine.
More from AGI Musings
- Oxford Intersections reopens call on AI & Relationships, abstracts due Dec 31 — dioscuri · 2026-11-13
- Leslie Pack Kaelbling to Debate Pure Behavior Learning vs Runtime Rationality in Robotics at Vector Institute — VectorInst · 2026-11-13
- Economists crunch METR data: no convincing evidence of an intelligence explosion yet — soumitrashukla9 · 2026-11-13
- Professor asks Claude to price a bare-bones college: still $20,389 a year — _akpiper · 2026-11-13
- As agentic AI hits superhuman speed, 'meaningful human oversight' may become an illusion — LuizaJarovsky · 2026-11-13
- Skeptic view: RL scaling is just compiler feedback plus IP siphoning — yacineMTB · 2026-11-13